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Background. Monitoring the epidemiology of cardiovascular risk factors (CRFs) and their determinants is important to develop
appropriate recommendations to prevent cardiovascular diseases in specific risk groups.TheNESCaV study was designed to collect
standardized data to estimate the prevalence of CRFs in relation to socioeconomic parameters among the general adult population
in the province of Lie`ge, Wallonia, Belgium.Methods. A representative stratified random sample of 1017 subjects, aged 20–69 years,
participated in the NESCaV study (2010–2012). A self-administered questionnaire, a clinical examination, and laboratory tests
were performed on participants. CRFs included hypertension, dyslipidemia, global obesity, abdominal obesity, diabetes, current
smoking, and physical inactivity. Covariates were education and subjective and objective socioeconomic levels. Data were analyzed
by weighted logistic regression. Results. The prevalence of hypertension, abdominal obesity, global obesity, current smoking, and
physical inactivity was higher in subjects with low education and who considered themselves “financially in need.” Living below
poverty threshold also increased the risk of global and abdominal obesity, current smoking, and physical inactivity.Conclusion.The
study shows that socioeconomic factors impact the prevalence of CRFs in the adult population of Wallonia. Current public health
policies should be adjusted to reduce health inequalities in specific risk groups.
1. Introduction
Cardiovascular diseases (CVD) are the first cause of death
worldwide [1–3]. In Europe, CVD are responsible for 47% of
all deaths (52% in women and 42% in men) with significant
differences inmortality rates between countries [1]. CVD also
contribute substantially to morbidity. In European countries,
CVD are responsible for 17% of all disability-adjusted life
years (DALYs) lost, making it the second largest single
cause after neuropsychiatric disorders [1]. The annual cost of
these diseases is estimated to amount to C196 billion in the
European Union (EU). Moreover, 54% of the costs are due to
direct health care budget, 24% to productivity losses, and 22%
to informal care of people with CVD [1].
In the last decades, CVD-related mortality has declined
markedly in many European countries [1–5]. The decreasing
trend has been attributed to changes in the prevention
and control of cardiovascular risk factors (CRFs) such as
lifestyle factors, especially tobacco, unhealthy diet habits, and
physical inactivity, and by the use of more effective medical
and surgical treatments [3]. Adequate changes in lifestyle-
related risk factors may prevent over 75% of all CVD deaths
according to the World Health Organization (WHO) [4].
The higher morbidity and mortality rates observed in
some specific groups, however, may be explained by the
higher prevalence of CRFs in these groups itself due to
socioeconomic differences such as educational level, occupa-
tional class, or income level [6, 7]. Adapted CVD prevention
remains a major challenge for eradicating, eliminating, or
minimizing the burden of CVD on health systems and
societies [3] and also for reducing health inequalities [7].
The bases of prevention are rooted in cardiovascular epi-
demiology and evidence-based medicine [4]. In this context,
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Wallonia in Belgium, and Lorraine in France, respectively,
faced with the lack of comparable data on cardiovascular
health in Europe, joined together to conduct the “Nutrition,
Environment and Cardiovascular Health” (NESCaV) project.
Its main goal was to build an epidemiological surveillance
tool for collecting standardized data to establish baseline
information on the prevalence of several potentially modifi-
able CRFs and, thus, generate some recommendations to pro-
mote efficiently cardiovascular health in the so-calledGreater
Region. The NESCaV study was designed under the auspices
of the European interregional program “INTERREG IV A”
and used a standard approach for the three participating
regions [8]. For the Belgian part, it was conducted in the
province of Lie`ge (Wallonia) between May 2010 and March
2012 by the Department of Public Health of the University of
Lie`ge, in collaborationwith theUniversity Hospital (CHU) of
Lie`ge.
The present work aimed (1) to determine the preva-
lence of potentially preventable and modifiable CRFs includ-
ing hypertension, dyslipidemia, global obesity, abdominal
obesity, diabetes, current smoking, and physical inactivity,
among the general adult population of Wallonia, and (2) to
investigate the potential impact of socioeconomic factors on
the CRFs.
2. Methods
2.1. Sampling Design. A representative stratified random
sample of subjects aged 20–69 years of the province of Lie`ge
was drawn from the Belgian national register of residents.
Stratification was made by gender, age, and district of resi-
dence. Pregnant women and people living in institutionswere
excluded. A power calculation showed that a sample size of at
least 1000 subjects was needed to estimate the prevalence of
risk factors with a statistical precision of at least 2% [8]. A
total of 1017 subjects eventually participated in the study. The
study design and information collected were approved by the
EthicsCommittee of the Faculty ofMedicine of theUniversity
of Lie`ge (B70720097541).
2.2. Method of Recruitment. To solicit selected subjects to
participate in the NESCaV project, an official letter was
sent by the investigators to explain the study objectives,
relevance to public health policies, ways of participation,
tests to be performed, and participant’s rights. Attached was
another letter addressed to the family physician to inform
and invite him/her to encourage participation of the subject
selected. To take part in the study, subjects could send their
initial agreement and phone number by using the coupon-
answer accompanying the official letter. They could also
phone or send an e-mail to the NESCaV research team.
Then, an appointment was made with the subject at the
nearest appointedmedical center involved in the study.Those
who refused to participate were no longer contacted and
were replaced by subjects presenting the same characteristics.
Whenever possible, subjects who did not respond sponta-
neously after one week were contacted again by phone. The
phone number was obtained from the telephone company.
At the visit, all participants were duly informed and signed
a consent form to take part in the study. Data consisted
of information collected from a self-administered question-
naire, a clinical examination, and laboratory tests (blood,
urine, and hair tests) for each participant. All participants
were informed about their measurements but laboratory test
results were sent to their family physician.
2.3. Anthropometric and Clinical Measurements. Anthropo-
metric and blood pressure measurements were performed
by trained health professionals according to standard rec-
ommendations [9, 10]. Before examination, participants were
asked to be fasting and to refrain from smoking for at least
8 hours. All patients were weighed on the same calibrated
digital scale (SECA 888; precision class I, 93/42/CEE) with
subject wearing light clothes without shoes. Subjects stood in
the center of the scale, with feet 25 cm apart, looking ahead,
and arms hanging freely [9–11]. Height was measured with
the same portable stadiometer (SECA 213; precision class I,
93/42/CEE) according to the following protocol: no shoes,
light clothes, no hair accessories, standing on guard against
the stadiometer, heels together, shoulders in relaxed position,
arms hanging freely, and knees straight [9–11]. Subjects were
standing with head straight so that the Frankfurt plane was
horizontal and eyes were focused forward. During measure-
ment, subjects took a deep breath and stood as straight as
possible [9–11]. Body mass index (BMI) was calculated using
the standard formula of body weight in kg divided by the
squared height inmeters (kg/m2) [9–11].Waist circumference
(WC, cm)wasmeasured to the nearest 0.1 cmwith the subject
in standing position, using a flexible, nondistensible tape
(SECA 201) and avoiding pressure exertion on the tissues,
at the level midway between 12th rib and the uppermost
lateral border of iliac crest during mild expiration with the
tape all around the body in horizontal position [9–11]. Blood
pressure was measured at least 3 times with a minimum of
1-minute interval between each measurement [11] by using
a digital automatic blood pressure monitor (OMRON M6
(HEM-7001-E(V)); precision ±3mmHg) with an appropriate
cuff size adapted to the upper arm perimeter (OMRONCL1).
Analyses were based on the mean values of the second and
third measurements of systolic (SBP, mmHg) and diastolic
blood pressure (DBP, mmHg).
2.4. Biochemical Parameters. A blood sample was collected
from each participant after an overnight 8-hour fast (includ-
ing abstaining from smoking). All samples were analyzed at
the Laboratory of the University Hospital of Lie`ge (CHU).
Fasting plasma glucose (FPG, mg/dL) was determined by
the enzymatic hexokinase method (Modular P, Roche).
Triglycerides concentration (TG,mg/dL)wasmeasured using
the enzymatic glycerol phosphate oxidase/PAP (Modular
P, Roche). An enzymatic method with cholesterol oxidase
(Modular P, Roche) was used in dosage of total cholesterol
(TC, mg/dL). Low-density lipoprotein cholesterol (LDL-C,
mg/dL) was assayed by inhibition of other fractions of choles-
terol and enzymatic colorimetric method with kit reagents
on Roche MODULAR P. High-density cholesterol (HDL-C,
mg/dL) was determined by enzymatic colorimetric method
with PEG-modified enzymes (Modular P, Roche).
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2.5. Socioeconomic and Lifestyle Factors. The self-admin-
istered questionnaire was used to collect information about
demographic and socioeconomic characteristics. In the
present study, participants were classified into three age-
groups: 20–29, 30–49, and 50–69 years old, respectively. Edu-
cational level was categorized into four classes: primary and
lower secondary, secondary, bachelor, and university degree.
“Subjective” economic level was assessed by asking part-
icipants if they had the feeling that their financial resources
allowed them to meet their household needs and was coded
as “in need” (from very difficult to difficult) or “well off”
(from rather easy to very easy). “Objective” economic level
was classified as either below or above risk of poverty thresh-
old. According to the Belgian Federal Government website,
the poverty threshold is equivalent to 60% of the median
disposable income at the individual level. For households, it
is calculated by multiplying the threshold of isolated people
by the household size. In the present study, subjects with an
income below this threshold were considered “below risk of
poverty threshold.”
Data regarding lifestyle characteristics, including family
and personal diseases history and medication intake, were
also collected with the self-administered questionnaire. Fam-
ily disease history was based on four questions aboutmyocar-
dial infarction, stroke, diabetes, and/or HTA within the par-
ticipant’s family. Personal disease historywas based on amore
comprehensive list of multiple choices of diseases related to
CVD. Nutritional habits were assessed with a validated food
frequency questionnaire [12] but not analyzed here.
2.6. Definition of CRFs. The study specifically focused on
7 distinct CRFs: hypertension, dyslipidemia, global obesity,
abdominal obesity, diabetes, current smoking, and physical
inactivity. Participants were classified as having hypertension
if they reported taking antihypertensive medications and/or
had SBP ≥ 140mmHg and/or DBP ≥ 90mmHg [11, 13].
Subjects with dyslipidemia were described as having at least
one of the following anomalies, TC ≥ 190mg/dL, TG ≥
150mg/dL, LDL-C ≥ 115mg/dL, and HDL-C < 40mg/dL for
men and< 46mg/dL for women, and/or taking lipid lowering
medications [11, 14]. Global obesity was defined as BMI ≥
30.0 kg/m2 according to theWHO[11, 15]. Abdominal obesity
was assessed as aWC ≥ 102 cm inmen and ≥ 88 cm in women
[11, 16]. Diabetes was defined when participant reported
taking antidiabetic medications and/or had FPG ≥ 126mg/dL
[11, 17]. Current smoking was defined on the basis of self-
reported responses (regular and occasional smoker), while
past or never smokers were considered nonsmokers. Physical
inactivity was defined as the practice of a sport (yes/no) less
than once a week (frequency of practice).
2.7. Statistical Analysis. Results were expressed as mean ±
standard deviation (SD) for normally distributed quantitative
variables and asmedian and interquartile range (P25–P75) for
the skewed variables. Frequencies were used to summarize
qualitative variables. The estimated prevalence of each CRF
was associated with its 95% confidence interval (95%CI).The
impact of age and gender on anthropometric, clinical, and
biological characteristics was assessed by a multiple linear
regression. Logistic regression analysis was applied to assess
the effect of age and gender on the prevalence of CRFs. It
was also used to test the potential effect of socioeconomic
factors on CRF prevalence. To account for the stratified
random sampling method, weighted statistical methods were
applied. A sampling weight equal to the inverse probability
of unit selection was allocated to each subject from the same
stratum. This stratum sampling weight was defined as the
ratio between the population stratum size and the observed
sample stratum size. Results were considered significant at
the 5% critical level (𝑃 < 0.05). All statistical analyses were
performed by using the SAS 9.3 survey procedure for complex
sampling design (© SAS Institute Inc., Cary, NC, USA).
3. Results
3.1. Study Subjects. The study enrolled 1017 subjects. Their
demographic and socioeconomic characteristics are given in
Table 1. There were 511 (50.1%) women and 506 (49.9%) men
with a median age of 45.1 years (IQR: 33.4–56.0). A majority
of participants (76.8%) reported no financial difficulties.
The anthropometric, clinical, and biological characteris-
tics of the subjects are presented in Table 2 by age category
and gender. All anthropometric, clinical, and biological
characteristics increased with advancing age (𝑃 < 0.0001),
except forHDL-Cwhich tended to remain stable (𝑃 = 0.095).
A significant gender effect was observed for BMI, WC, SBP,
DBP, FPG, HDL-C, LDL-C, and TG where men had higher
levels than women, except for HDL-C where levels were
lower. TC was not influenced by gender (𝑃 = 0.16).
3.2. Epidemiology of CRFs. By decreasing order of prevalence
(Table 3), themost predominantCRFwas dyslipidemia 65.7%
(95% CI: 62.8–68.6), followed by physical inactivity 55.2%
(95% CI: 52.2–58.1), hypertension 31.2% (95% CI: 28.4–
34.0), current smoking 25.0% (95%CI: 22.4–27.6), abdominal
obesity 23.0% (95% CI: 20.5–25.5), global obesity 18.3% (95%
CI: 16.0–20.6), and diabetes 6.5% (95% CI: 5.0–8.0). The
prevalence of all CRFs increased with age, except for current
smoking where the prevalence decreased with age. Concern-
ing gender, the prevalence of hypertension, dyslipidemia, and
current smoking was higher in men than women. Physical
inactivity concerned more women than men. Both men
and women were equally affected by global and abdominal
obesity, as well as diabetes.
3.3. Relations between Socioeconomic Factors and CFRs.
Table 4 presents the age-, gender-, and district-adjusted odd
ratios for all CRFs according to socioeconomic factors.
Hypertension, global obesity, abdominal obesity, current
smoking, and physical inactivity were more frequent in
subjects with low education level. Subjects who consider
themselves “in need” were at a higher risk to present
hypertension (OR = 1.65; 95% CI: 1.18–2.32), global obesity
(OR = 1.91; 95% CI: 1.34–2.74), abdominal obesity (OR =
2.07; 95% CI: 1.46–2.94), current smoking (OR = 1.89; 95%
CI: 1.37–2.61), and physical inactivity (OR = 2.40; 95% CI:
1.75–3.31) than people who consider themselves “well off.”
People living below risk of poverty threshold were more
4 BioMed Research International
Table 1: Demographic and socioeconomic characteristics of the study subjects (𝑁 = 1017).
Variable Category 𝑛 Frequency (%) Median (IQR)












Subjective economic level 1013
In need 235 (23.2)
Well off 778 (76.8)
Objective economic level 932
Below risk of poverty threshold 169 (18.1)
Above risk of poverty threshold 763 (81.9)
Table 2: Anthropometric, clinical, and biological characteristics by age category and gender in the NESCaV sample (𝑁 = 1017).
Characteristic Age category (years) 𝑃 valuea 𝑃 valueb
20–29 30–49 50–69
Number of subjects (male/female) 200 (100/100) 436 (218/218) 381 (188/193)
BMI (kg/m2)
Male 24.9 ± 0.5 26.5 ± 0.3 28.1 ± 0.3
<0.0001 <0.0001
Female 23.3 ± 0.5 24.8 ± 0.3 26.9 ± 0.4
WC (cm)
Male 84.9 ± 1.2 91.0 ± 0.8 98.4 ± 0.9
<0.0001 <0.0001
Female 73.9 ± 1.0 79.3 ± 0.8 85.5 ± 1.0
SBP (mmHg)
Male 127.4 ± 1.2 127.7 ± 0.9 134.8 ± 1.2
<0.0001 <0.0001
Female 111.7 ± 1.2 114.0 ± 0.9 126.3 ± 1.2
DBP (mmHg)
Male 74.4 ± 0.8 78.9 ± 0.7 82.7 ± 0.7
<0.0001 <0.0001
Female 69.4 ± 1.0 73.8 ± 0.7 77.3 ± 0.8
FPG (mg/dL)
Male 85.3 ± 0.6 91.4 ± 1.1 100.4 ± 2.3
<0.0001 <0.0001
Female 79.8 ± 0.6 84.9 ± 0.9 91.5 ± 1.7
HDL-C (mg/dL)
Male 57.0 ± 1.4 53.6 ± 0.9 54.5 ± 1.1 0.095 <0.0001
Female 67.6 ± 1.4 66.6 ± 1.1 69.4 ± 1.3
LDL-C (mg/dL)
Male 103.5 ± 3.1 126.0 ± 2.1 127.5 ± 2.6
<0.0001 0.002
Female 96.5 ± 2.7 111.4 ± 2.0 130.9 ± 2.5
TC (mg/dL)
Male 174.5 ± 3.3 198.9 ± 2.5 203.4 ± 2.9
<0.0001 0.16
Female 179.0 ± 3.1 191.5 ± 2.4 217.9 ± 2.7
TG (mg/dL)
Male 88.1 ± 5.7 115.8 ± 5.2 124.9 ± 5.3
<0.0001 <0.0001
Female 88.5 ± 3.8 78.6 ± 2.7 102.6 ± 4.4
aAge effect, bgender effect.
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Table 3: Prevalence of CRFs by age category and gender in the NESCaV sample (𝑁 = 1017).
CRFs
Age category (years)
𝑃 valuea 𝑃 valueb20–29 30–49 50–69
𝑛 (%) 𝑛 (%) 𝑛 (%)
Hypertension
Total 317 (31.2)
Male 21 (10.4) 58 (13.4) 115 (29.9)
<0.0001 <0.0001
Female 5 (2.5) 34 (7.74) 84 (22.3)
Dyslipidemia
Total 653 (65.7)
Male 38 (19.8) 153 (36.1) 162 (43.1)
<0.0001 <0.0001
Female 34 (17.4) 110 (25.5) 156 (42.0)
Global obesity
Total 186 (18.3)
Male 13 (6.59) 36 (8.34) 48 (12.5)
<0.0001 0.41
Female 9 (4.48) 31 (7.01) 49 (12.9)
Abdominal obesity
Total 234 (23.0)
Male 7 (3.47) 32 (7.36) 71 (18.5)
<0.0001 0.35
Female 10 (4.96) 37 (8.42) 77 (20.3)
Diabetes
Total 65 (6.52)
Male 1 (0.50) 8 (1.89) 27 (7.21)
<0.0001 0.32
Female 2 (0.99) 10 (2.33) 17 (4.53)
Current smoking
Total 253 (25.0)
Male 37 (18.8) 56 (13.2) 45 (11.9) 0.001 0.048
Female 32 (16.0) 47 (10.5) 36 (9.32)
Physical inactivity
Total 561 (55.2)
Male 39 (19.6) 110 (25.4) 114 (29.6) 0.001 0.035
Female 52 (26.0) 127 (28.9) 119 (31.5)
aAge effect, bgender effect.
disposed to present global obesity (OR = 2.0; 95% CI: 1.34–
2.98), abdominal obesity (OR = 2.02; 95% CI: 1.36–2.99),
current smoking (OR = 1.60; 95% CI: 1.09–2.33), and physical
inactivity (OR = 1.86; 95% CI: 1.30–2.66) as compared to
people living above risk of poverty threshold.
From a multivariable perspective (Table 5), low level of
education was associated with hypertension (𝑃 = 0.045),
global obesity (𝑃 = 0.031), abdominal obesity (𝑃 < 0.0001),
current smoking (𝑃 = 0.020), and physical inactivity (𝑃 =
0.016). Concerning subjective economic level, subjects who
consider themselves “in need” were more concerned by
hypertension (OR= 1.56; 95%CI: 1.05–2.33), current smoking
(OR = 1.57; 95% CI: 1.09–2.28), physical inactivity (OR =
2.04; 95% CI: 1.42–2.93), and abdominal obesity (OR = 1.54;
95% CI: 1.01–2.36) than people living above risk of poverty
threshold.
4. Discussion
Mortality and morbidity associated with CVD continue to
have amajor socioeconomic impact in Europe and contribute
to significant health inequalities. In Belgium, CVD are the
first cause of death. Monitoring the epidemiology of CRFs is
important to develop some appropriate recommendations to
prevent CVD especially in specific risk groups.
According to the present NESCaV findings, dyslipidemia
was the most predominant risk factor for the targeted popu-
lation of Wallonia, followed by physical inactivity, hyperten-
sion, current smoking, abdominal obesity, global obesity, and
diabetes. The same observations were made in Grand-Duchy
of Luxembourg (GLD) (ORISCAV-LUX) where dyslipidemia
concerned 69.9%, hypertension 34.5%, current smoking
22.3%, global obesity 20.9%, and diabetes 4.4% [11]. Except
for diabetes and current smoking, the Belgian population
evidenced lower prevalence of aforementioned CRFs. This
high risk profile correlated well with the mortality rate of
CVD, respectively, 36.5% in 2009 in Grand-Duchy of Luxem-
bourg [18] and 31.4% in the same year in Belgium [19]. The
comparison with other prevalence studies is difficult because
of important methodological differences, sociodemographic
profiles differences of the study subjects, and the definition
of CRFs that were used. However, the Canadian Health
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Measures Survey (CHMS) in 2007–2009 indicated 27.1% for
hypertension prevalence, 23.0% for current smoking, 22.5%
for dyslipidemia, 22.2% for global obesity, and 6.9% for
diabetes. The 2005–2008 US National Health and Nutrition
Examination Survey (NHANES) reported a prevalence of
40.2% for hypertension, 33.8% for global obesity, 25.9%
for dyslipidemia, 24.8% for current smoking, and 11.1%
for diabetes [20]. The large difference in the prevalence of
dyslipidemia between the results of these two studies and the
NESCaV study may probably be explained by a difference in
the definition of dyslipidemia.
The prevalence of dyslipidemia, current smoking, and
hypertension was significantly higher inmen than in women.
These observations were consistent with findings of the
ORISCAV-LUX survey, except for global obesity. Physical
inactivity was more frequent in women than in men. The
same observation was made in the 2014 Eurobarometer
survey on physical activity [21]. The prevalence of other
CRFs was not associated with gender. The absence of gender
difference for abdominal obesity is interesting. Typically, men
are more affected by abdominal obesity and women are more
affected by gynoid obesity [22]. In our study,men andwomen
were equally affected by intra-abdominal adiposity (𝑃 =
0.35). A recent study in the United States showed that abdo-
minal obesity increased in women between 1999 and 2008
[23]. This is a public health problem which needs to be
monitored because abdominal obesity is an indicator of vis-
ceral fat accumulation [24] and a predictor of adverse meta-
bolic or cardiovascular outcomes independently of bodymass
[22].
Physical inactivity, current smoking, global obesity, and
abdominal obesity were associated with lower educational
and subjective and/or objective economic levels. The preva-
lence of hypertension was also higher in subjects with low
educational level and low subjective economic level. These
findings once again indicate that lower socioeconomic groups
are associated with unfavorable cardiovascular risk factor
profiles. Moreover, they were consistent with socioeconomic
inequalities in cardiovascular mortality observed in indus-
trialized countries [6]. Two hypotheses have been proposed
to explain the relation between health and socioeconomic
status.The first hypothesis, the social causation, suggests that
the socioeconomic status influences health and the second
hypothesis, the social selection, suggests that poor health
limits individual’s educational and occupational achieve-
ments, leading to lower socioeconomic status in adulthood.
Elovainio et al. showed that the relation between socioeco-
nomic status and health is not only unidirectional. In their
study, they observed that social selection operates at younger
age and social causation contributes to socioeconomic dif-
ferences in cardiometabolic health in midlife [25]. More
attention should be paid to disadvantaged socioeconomic
groups for CVD prevention at each stage of life.
The prevalence of current smoking was the same as the
prevalence observed in the Belgian Health Interview Survey
in 2008 (25%) [26]. In Luxembourg, current smoking con-
cerned 22.3% of the general population [11]. In the European
Union, 26% of people aged 15 years and older are current
daily smokers [27]. Because smoking cessation reduces the
risk of CVD and premature death [28], further efforts should
be made to fight smoking in specific risk groups.
In this survey, 44.8% of the subjects reported practicing
a sport at least once a week, slightly higher than in EU (41%)
[21]. These low prevalence rates show the need to promote
physical activity because of its association with favorable
effects on most CRFs, namely, abdominal obesity, dyslipi-
demia, global obesity, insulin sensitivity, and blood pressure
[29]. Increasing physical activity is one of WHO recommen-
dations to prevent CVD morbidity and mortality [30].
The main strength of the present study was a fair repre-
sentativeness of the population of Wallonia aged 20–69 years
and the large sample size (𝑛 = 1017). However, the exclusion
of people living in institutions could decrease the prevalence
of CRFs. Another strong point was the use of standardized
tools and methods for performing physical and laboratory
measurements to define CRFs. This should facilitate national
and international comparability as recommended by the
WHO stepwise approach [31]. Nonetheless, the information
about physical activity, smoking, hypertension treatment,
dyslipidemia, and diabetes was self-reported and may be
subject to social desirability bias or recall bias. The cross-
sectional design of our study was another limitation that
makes it difficult to establish causal relations.
5. Conclusion
The mortality rate related to CVD has decreased in Belgium
in the last decades but the present findings demonstrate
that the cardiovascular risk profile in Wallonia is still a
matter of public health concern. Moreover, they show that
subjects with low socioeconomic status, as indicated by
educational level and subjective and objective economic level,
have an unfavorable cardiovascular risk factors profile. This
highlights the importance of adjusting the current public
health policies towards those disadvantaged groups to reduce
health inequalities.
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